Osteoclast Inhibitors for Knee Conditions
First Claim
Patent Images
1. A method of treating hyperalgesia associated with complex regional pain syndrome, comprising parenterally administering neridronic acid in a salt or an acid form to a human being suffering from hyperalgesia associated with complex regional pain syndrome.
3 Assignments
0 Petitions
Accused Products
Abstract
Oral dosage forms of osteoclast inhibitors, such as neridronic acid, in an acid or a salt form can be used to treat or alleviate pain or related conditions, such as complex regional pain syndrome.
34 Citations
30 Claims
- 1. A method of treating hyperalgesia associated with complex regional pain syndrome, comprising parenterally administering neridronic acid in a salt or an acid form to a human being suffering from hyperalgesia associated with complex regional pain syndrome.
- 17. A method of treating edema associated with complex regional pain syndrome, comprising parenterally administering neridronic acid in a salt or an acid form to a human being suffering from edema associated with complex regional pain syndrome.
Specification